Ozempic, Wegovy, semaglutide and other GLP-1 agonists are excellent weight loss and diabetes management drugs. They have a significant effect on stomach emptying that puts patients having surgery at higher risk.
Dr. Richard Hilsden discusses the risks of these types of drugs for patients undergoing surgical procedures.
These drugs work, in part, by slowing the emptying of the stomach. This is an excellent effect that helps patients lose weight and control their diabetes; however, when it comes to surgery this increases the risk to the patients.
The American Society of Anesthesiologists now recommends stopping these medications more than 1 week prior to surgery.
Follow me on socials:
Instagram
/ hilsdenr
TikTok
/ rich_hilsden
Смотрите видео Ozempic and Surgery Risks! A surgeon's warning онлайн без регистрации, длительностью часов минут секунд в хорошем качестве. Это видео добавил пользователь Knife Skills 06 Октябрь 2023, не забудьте поделиться им ссылкой с друзьями и знакомыми, на нашем сайте его посмотрели 1,40 раз и оно понравилось 6 людям.